(cyclohexylmethyl)methylamine hydrochloride, 95.0%, 5g

4-(3,4-Dimethylphenyl)-thiazol-2-ylamine, 95.0%, 5g

Gliquidone>98.0%(HPLC)(T)1g

1-Bromo-2-chloroethane, >98.0%(GC), 5g

Methyl Orange>98.0%(HPLC)25g

Methyl 3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98%, 5g

2-[1,2,4]Triazol-1-yl-benzaldehyde, 95.0%, 10g

(2S)-2-(4-(3-Amino-1,9-dioxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl)benzamido)pentanedioic acid, 95%, 10mg

Reversible frit 250 ml, 3 (16 – 40 μm), 1 Piece

(1S)-2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diamine, 98%, 100mg

4-Thiazolidinone, 2-thioxo-5-[[4-(trifluoromethyl)phenyl]methyl]-, 98%, 1g

Tube connection stopper, 1 Piece

2-Bromo-4-methylthiophene, 95.0%, 1g